Stocks
Intra-Cellular Therapies (ITCI) P/E US GAAP (year values) |
|||||||||
| 2020 | 2021 | 2022 | 2023 | 2024 | LTM ? | CAGR 5 years ? | |||
| P/E | ? | -9.86 | -15.0 | -19.4 | -49.2 | -115.3 | -182.1 | ||
| Changes by years, y/y, % | -23% | +52% | +30% | +153% | +135% | +55.2% | |||
Intra-Cellular Therapies. P/E
Intra-Cellular Therapies. P/E, changes, %
Intra-Cellular Therapies (ITCI) P/E US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | 2024Q4 | LTM ? | |||
| P/E | ? | -49.4 | -60.5 | -84.3 | -89.6 | -115.3 | -182.1 | |
| Changes by years, y/y, % | +143% | +157% | +146% | +165% | +134% | |||
| Changes by quarters, q/q, % | +46% | +22% | +39% | +6% | +29% | |||
